EARN25

FDA Nod Could Rattle Array Biopharma Shorts

The FDA gave a major boost to Array's colorectal cancer treatment

Aug 7, 2018 at 9:17 AM
facebook X logo linkedin


Boulder-based Array Biopharma Inc (NASDAQ:ARRY) is attracting pre-market attention this morning, after its BRAFTOVI drug, in combination with MEKTOVI and cetuximab, was given a Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the treatment of mutant metastatic colorectal cancer. The FDA nod means the drug development and review process will be expedited.

ARRY is up 8.7% in electronic trading, after closing Monday's session at $15.07. The stock is in the process of bouncing from support at its 200-day moving average, which previously contained its May lows around the $13 level.

Despite a choppy price trend in 2018, ARRY was up 17.7% year-to-date through last night's close. And based on the security's early momentum, the biopharmaceutical concern looks set to rally back above its historically significant 160-day moving average, as well.

If short sellers are rattled by Array Biopharma stock's surge, a short-covering rush could translate into a sustained move higher. Short interest accounts for 8.4% of the equity's float, or seven times ARRY's average daily trading volume. This leaves the stock well-positioned to capitalize on an unwinding of these bearish bets.

 

 

You Don’t Need 25 Alerts -- You Need ONE You Can Trust!

That’s the idea behind Trade of the Week, Schaeffer’s newest trade alert.

Every Monday morning before the opening bell, you’ll receive a single, expertly researched trade recommendation -- built from the same proprietary research we’ve been using for over four decades.

It’s not just a signal.

It’s a plan designed for traders who are tired of jumping from alert to alert without ever finding their edge.

No juggling alerts. No switching directions mid-week. Just one clear, expertly researched trade idea -- delivered before the market even opens.

👉 JOIN RIGHT NOW FOR JUST $1 TO GET THE NEXT TRADE!